Skip to main content
. 2020 Oct 6;123(12):1790–1795. doi: 10.1038/s41416-020-01111-0

Table 3.

HPV detection using RNAseq in HPV PCR negative specimens.

n (Total 392) % Total (95% CI)
HPV Negative by RNAseq 223 56.89 (51.82–61.85)
HPV Positive by RNAseq 169 43.11 (38.15–48.18)
HPV 16 4 1.02 (0.28–2.59)
HPV 18 1 0.26 (0.01–1.41)
HPV 31 19 4.85 (2.94–7.47)
HPV 32 1 0.26 (0.01–1.41)
HPV 33 58 14.80 (11.43–18.70)
HPV 34 3 0.77 (0.16–2.22)
HPV 35 3 0.77 (0.16–2.22)
HPV 38 1 0.26 (0.01–1.41)
HPV 39 8 2.04 (0.89–3.98)
HPV 42 2 0.51 (0.06–1.83)
HPV 45 17 4.34 (2.55–6.85)
HPV 52 2 0.51 (0.06–1.83)
HPV 53 2 0.51 (0.06–1.83)
HPV 54 1 0.26 (0.01–1.41)
HPV 56 8 2.04 (0.89–3.98)
HPV 58 8 2.04 (0.89–3.98)
HPV 59 4 1.02 (0.28–2.59)
HPV 66 1 0.26 (0.01–1.41)
HPV 68 1 0.26 (0.01–1.41)
HPV 70 1 0.26 (0.01–1.41)
HPV 73 23 5.87 (3.76–8.67)
HPV 82 1 0.26 (0.01–1.41)

Number of HPV PCR negative specimens that turn HPV positive after being subjected to RNAseq. Highlighted with bold HPV genotypes are the types which present specific probes for the PCR-based detection method.